📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
30
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
59%
📜 Warrant Exercise
60%
• Massive warrant overhang: 81% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion
60%
• Major convertible overhang: 43% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
55%
• Score rose 61 points recently (worsening)
• Score already CRITICAL (80/100) — events likely imminent
💹 Market Data
Market Cap$85.49M
Shares Outstanding12.78M
Float10.43M
Cash$5.94M
Debt$22.05M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 146.7% shares (2025Q4 vs prior)
28 institutional holders · 1.94M shares
#1
SymBiosis Capital Partners, LLC
770.5K shares
#2
SCOGGIN MANAGEMENT LP
275.0K shares
#3
VANGUARD GROUP INC
222.9K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest875.0K
Days to Cover11.5
% of Float8.4%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
4
INSIDER TRANSACTION
Apr 30, 2026
4
INSIDER TRANSACTION
Apr 22, 2026
4
INSIDER TRANSACTION
Apr 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CLNN
📊 CLNN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CLNN Signal Convergence & Dark Pool Activity — StonkWhisper
📄 CLNN Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.